Patents by Inventor Gitte Boehm

Gitte Boehm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diagnosis and prognosis of colorectal cancer
    Patent number: 9095549
    Abstract: The invention relates to a method of diagnosis of colorectal cancer in a diagnostic sample of a valid body tissue taken from a human subject, which comprises detecting an increased concentration of a protein in the diagnostic sample, compared with a control, normal human sample, the protein being: transforming growth factor-beta induced protein IG-H3 (SwissProt Acc. No. Q15582); suppressor of G2 allele of SKP1 homolog (isoform 2) (SwissProt Acc. No. Q9Y2Z0-2); hypothetical protein (part of URG4) (SwissProt Acc. No. Q9NWR7); calponin-2 (SwissProt Acc. No. Q99439); heat shock protein HSP90-beta (SwissProt Acc. No. P08238); phosphoglycerate mutase 1 (SwissProt Acc. No. P18669); serpin C1 protein (SwissProt Acc. No. P01008); or haptoglobin precursor (SwissProt Acc. No. P00738); or a decreased concentration of a protein in the diagnostic sample, compared with a control, normal human sample, the protein being serotransferrin (SwissProt Acc. No. P02787); 26S proteasome subunit p40.5 (Swiss Prot Acc. No.
    Type: Grant
    Filed: December 15, 2006
    Date of Patent: August 4, 2015
    Assignee: ELECTROPHORETICS LIMITED
    Inventors: Richard Joubert, Petra Prefot, Gitte Boehm, Juergen Arnhold, Claudia Hoehle, Erhard Neukum, Juergen Schaefer
  • DIAGNOSIS AND PROGNOSIS OF COLORECTAL CANCER
    Publication number: 20090226905
    Abstract: The invention relates to a method of diagnosis of colorectal cancer in a diagnostic sample of a valid body tissue taken from a human subject, which comprises detecting an increased concentration of a protein in the diagnostic sample, compared with a control, normal human sample, the protein being: transforming growth factor-beta induced protein IG-H3 (SwissProt Acc. No. Q15582); suppressor of G2 allele of SKP1 homolog (isoform 2) (SwissProt Acc. No. Q9Y2Z0-2); hypothetical protein (part of URG4) (SwissProt Acc. No. Q9NWR7); calponin-2 (SwissProt Acc. No. Q99439); heat shock protein HSP90-beta (SwissProt Acc. No. P08238); phosphoglycerate mutase 1 (SwissProt Acc. No. P18669); serpin Cl protein (SwissProt Acc. No. P01008); or haptoglobin precursor (SwissProt Acc. No. P00738); or a decreased concentration of a protein in the diagnostic sample, compared with a control, normal human sample, the protein being serotransferrin (SwissProt Acc. No. P02787); 26S proteasome subunit p40.5 (Swiss Prot Acc. No.
    Type: Application
    Filed: December 15, 2006
    Publication date: September 10, 2009
    Inventors: Richard Joubert, Petra Prefot, Gitte Boehm, Juergen Arnhold, Claudia Hoehle, Erhard Neukum, Juergen Schaefer
  • Biodegradable polymers based on natural and renewable raw materials especially isosorbite
    Patent number: 6342300
    Abstract: The invention relates to biodegradable polycondensates, to the production of said polycondensates, and to their use for releasing specific substances. The polycondensates are derived from at least three components chosen from the following group: a) dianhydrohexites b) bivalent (polyvalent) organic carboxylic acids and c) polyvalent organic carboxylic acids which, in addition to two carboxylic acid functions, have at least one other, optionally capped, i.e., OH and/or COOH function.
    Type: Grant
    Filed: September 7, 2000
    Date of Patent: January 29, 2002
    Assignee: Celanese Ventures GmbH
    Inventors: Holger Bengs, Alex Schoenfeld, Gitte Boehm, Siegfried Weis, Joachim Clauss